Frontlight ResearchEarly access
Trial site
Toyoake
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- IgA nephropathy3 trials
- Childhood cancers2 trials
- Aplastic anaemia1 trial
- Chronic kidney disease1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Myeloproliferative neoplasms1 trial
- Spinal muscular atrophy1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed5 trials
- Recruiting5 trials
- Active, not recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Recruiting
Active, not recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aplastic anaemia1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Spinal muscular atrophy1 recruiting
Closed trials
Completed
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026